Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04802395 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04802395 · ClinicalTrials.gov record · last posted 2026-08-13

Real World Evidence Clinical Utility Study of KidneyIntelX

StatusRecruiting
PhaseNot specified
Started2021-03-02
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office at Mount Sinai.

Protocol amendment history 1 change detected by DataLookout

2026-08-14
Primary completion pushed: 2024-12-02 → 2026-12-01
Trial Details
NCT Number NCT04802395
Lead Sponsor Renalytix AI, Inc.
Collaborators: Mount Sinai Hospital, New York
Conditions Chronic Kidney Diseases, Diabetic Kidney Disease
Enrollment 10,000 participants
Start Date 2021-03-02
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13